Deliver Your News to the World

Agilent Technologies Appoints Fasteris First European Certified-Service Provider for Agilent’s Next-Generation Sequencing Target Enrichment System


SANTA CLARA, Calif. and GENEVA, Switzerland, Agilent Technologies Inc. (NYSE: A) and Fasteris SA today announced that Fasteris has been named the first European Certified-Service Provider (CSP) for Agilent’s SureSelect Target Enrichment System for next-generation sequencing.

SureSelect, introduced in February 2009, has been shown to greatly increase the speed and cost-efficiency of next-generation sequencing workflows used in life science research by enabling experiments to focus on genomic regions of interest rather than sequencing the entire genome.

Fasteris achieved CSP status for the SureSelect Target Enrichment System after demonstrating a high level of proficiency using the SureSelect system with the Illumina Genome Analyzer.

“Fasteris is a pioneer in next-gen sequencing, and we’re delighted that they’ll be combining the efficiencies of SureSelect with their expertise on the Illumina Genome Analyzer,” said Fred Ernani, Ph.D., Agilent senior product manager for Emerging Genomics Applications. “Having Fasteris as an Agilent-certified service provider promises to deliver real value to the genomics community.”

“We have been impressed by the SureSelect technology with its high proportion of reads on target and resulting reduction in downstrean sequencing costs on the Illumina Genome Analyzer,” said Laurent Farinelli, Ph.D., Fasteris founder and CEO. “We are very pleased to work in collaboration with Agilent to provide customers with highest quality service.”

The Agilent SureSelect Target Enrichment System is based on an in-solution design, making it automation-friendly and easily scalable from 10 reactions through thousands.

Users can design their own custom SureSelect kits using Agilent’s eArray online design tool, which contains many key genomes and also lets users upload their own sequences. Because sample requirement is 3 micrograms or less of gDNA, researchers can perform highly targeted next-generation sequencing on very precious samples.

Agilent and Illumina have a non-exclusive co-marketing agreement to support the Agilent SureSelect Target Enrichment System optimized for the Illumina Genome Analyzer.


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.